Literature DB >> 1958974

Frequency of familial colorectal cancer.

B M Stephenson1, P J Finan, J Gascoyne, F Garbett, V A Murday, D T Bishop.   

Abstract

Familial clustering of cancer is not uncommon. The frequency of familial colorectal cancer was estimated by taking family histories from 100 patients presenting with apparently sporadic colorectal cancer. Compared with controls, the relative risk of a positive family history for colorectal cancer was 4.6. Life-table methods were used to examine the observed to expected mortality from colorectal cancer. Overall there was a fourfold increase in mortality rate (P less than 0.0001), which was greatest in female relatives of patients with colonic cancer (P less than 0.001). Three families with dominant inheritance of colorectal cancer and one family with Lynch type II syndrome were identified. Nine per cent of patients had siblings who had developed colorectal cancer a median of 4 years before the diagnosis of the index patient (range 1-17 years). It is recommended that a careful family history should be obtained from all patients with colorectal cancer. Where a positive history is obtained a geneticist may determine empirical risks for the development of colorectal cancer and the appropriate method of surveillance may be selected.

Entities:  

Mesh:

Year:  1991        PMID: 1958974     DOI: 10.1002/bjs.1800781005

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  29 in total

1.  Guidance on large bowel surveillance for people with two first degree relatives with colorectal cancer or one first degree relative diagnosed with colorectal cancer under 45 years.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

2.  Association between family history and mismatch repair in colorectal cancer.

Authors:  R P Coggins; L Cawkwell; S M Bell; G P Crockford; P Quirke; P J Finan; D T Bishop
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

3.  Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.

Authors:  L M Hunt; P S Rooney; K Bostock; M H Robinson; J D Hardcastle; N C Armitage
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

4.  Increased incidence of cancer in first degree relatives of women with double primary carcinomas of the breast and colon.

Authors:  W D Foulkes; N Bolduc; D Lambert; O Ginsburg; L Olien; D W Yandell; P N Tonin; S A Narod
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

5.  Frequency of replication errors in colorectal cancer and their association with family history.

Authors:  S R Brown; P J Finan; L Cawkwell; P Quirke; D T Bishop
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

6.  Are relatives of patients with multiple HNPCC spectrum tumours at increased risk of cancer?

Authors:  S R Brown; P J Finan; D T Bishop
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

7.  Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer.

Authors:  Robert E Schoen; Anthony Razzak; Kelly J Yu; Sonja I Berndt; Kevin Firl; Thomas L Riley; Paul F Pinsky
Journal:  Gastroenterology       Date:  2015-08-05       Impact factor: 22.682

Review 8.  Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review.

Authors:  A P Knopperts; M Nielsen; R C Niessen; C M J Tops; B Jorritsma; J Varkevisser; J Wijnen; C L E Siezen; R C Heine-Bröring; H J van Kranen; Y J Vos; H Westers; E Kampman; R H Sijmons; F J Hes
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

9.  Family history of colorectal cancer in a Sweden county.

Authors:  Louise Olsson; Annika Lindblom
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

10.  Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice.

Authors:  B M Stephenson; V A Murday; P J Finan; P Quirke; M F Dixon; D T Bishop
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.